What is hospital-at-home, and is recovering there safe?

The concept of receiving hospital-level care in the comfort of one's own home is rapidly moving from a niche pilot program to a mainstream service line for health systems across the country. Known as hospital-at-home (HaH), this model provides acute care to eligible patients in their residences, using a combination of in-person visits, telehealth, and remote monitoring technologies. For hospital administrators and clinical leaders, the question is no longer if this model is feasible, but how to implement it safely and effectively. The data shows that for many patients, recovering at home is Preferred. May also lead to better outcomes.

"A landmark randomized controlled trial for hospital-at-home found that the model reduced direct healthcare costs by 38% compared to traditional inpatient care, while also lowering readmission rates and increasing physical activity among patients."

The shift to home-based acute care

Hospital-at-home is a care delivery model that allows patients with common acute conditions like pneumonia, heart failure, and COPD to receive hospital-level treatment without being admitted to a physical hospital building. This approach has gained significant traction, accelerated by the need for hospital capacity during the COVID-19 pandemic and supported by new payment models from payers like the Centers for Medicare & Medicaid Services (CMS). The core of a successful program hinges on a robust system for hospital at home vital signs monitoring, which allows the clinical team to track a patient's condition in real time and intervene before a potential decline.

This model fundamentally rethinks the logistics of acute care. Instead of centralizing patients in one building, it deploys a distributed network of clinicians, equipment, and services to the patient. Research shows this approach can be highly effective. A systematic review published in BMJ Open found that HaH care was associated with comparable or improved clinical outcomes, including lower mortality and readmission rates, when compared to traditional inpatient settings.

| Feature | Traditional Inpatient Care | Hospital-at-Home | | :--- | :--- | :--- | | Care Setting | Centralized hospital facility | Patient's own home | | Clinical Staffing | On-site nurses and physicians | Mobile clinicians, telehealth | | Patient Experience | Disruption of routine, risk of nosocomial infections | Familiar environment, family support, lower infection risk | | Readmission Rates | Variable; a key focus for reduction | Often lower than inpatient care for same conditions | | Technology Used | Centralized monitoring stations, wired equipment | Remote patient monitoring (RPM) devices, telehealth platforms | | Cost of Care | Higher due to facility overhead and staffing ratios | Significantly lower direct and indirect costs |

Industry Applications

Health systems are adopting the HaH model for several strategic reasons, primarily centered around capacity management, cost reduction, and patient satisfaction.

### managing hospital capacity

For hospitals operating at or near full capacity, HaH provides a crucial "pressure relief valve." By decanting stable, acute-care patients to a home setting, hospitals can free up inpatient beds for higher-acuity or emergency cases. This allows for more flexible management of patient flow and can prevent costly and inefficient emergency department diversions.

### serving specific patient populations

HaH programs are proving particularly effective for:

• Patients with chronic diseases prone to acute exacerbations (e.g., COPD, CHF)
• Patients needing post-operative care after certain surgeries
• Patients with infections like pneumonia or cellulitis who do not require ICU-level care

### reducing total cost of care

By reducing length of stay and preventing readmissions, HaH directly impacts the total cost of care for an episode. This is a critical metric for health systems engaged in value-based care contracts with payers. The operational efficiencies, such as reduced need for certain facility services, further contribute to a lower cost structure.

Current research and evidence

The evidence base supporting the safety and efficacy of hospital-at-home has grown substantially in recent years. A key figure in this field is Dr. David Levine of Brigham and Women's Hospital and Harvard Medical School. A randomized controlled trial he co-authored in 2020 provided strong evidence for the model's benefits. The study, published in the Annals of Internal Medicine, found that for acutely ill adults, home hospitalization led to lower readmission rates and lower total costs of care compared to traditional hospital stays.

The critical component enabling these outcomes is the continuous flow of objective data. The effective use of hospital at home vital signs monitoring is a recurring theme in the research. A systematic review in the Journal of Medical Internet Research (2022) examined the value of remote vital signs monitoring in HaH programs. While concluding that more high-quality studies are needed, the review noted that existing evidence points toward remote monitoring being a key factor in the early detection of clinical deterioration. This ability to "see" a patient's trajectory between physical visits is what builds clinician confidence and ensures patient safety in a home setting.

The future of hospital-at-home

The future of HaH is inextricably linked with advancements in remote patient monitoring (RPM) technology. While early programs relied heavily on periodic in-person checks and manual vital sign collection, the trend is toward more continuous and less intrusive methods. The challenge for many programs is the logistical burden of distributing, training for, and retrieving wearable devices like pulse oximeters and blood pressure cuffs. Patient adherence to using these devices consistently can also be a significant barrier.

This is where contactless monitoring technologies are beginning to draw interest. Platforms that can capture vital signs using the camera on a patient's existing smartphone or tablet remove the friction associated with traditional hardware. This approach simplifies logistics for the health system and reduces the compliance burden on the patient, potentially leading to a more consistent and reliable stream of data. As these technologies mature, they promise to make the collection of hospital at home vital signs even more seamless, further securing the HaH model as a safe and scalable component of the care continuum.

Frequently asked questions

Q: What types of patients are eligible for hospital-at-home? A: Eligibility is determined by clinicians based on the patient's diagnosis, clinical stability, and home environment. Common conditions include heart failure, COPD, pneumonia, and cellulitis. Patients must have a safe and stable home environment to be considered.

Q: How are vital signs monitored remotely and kept secure? A: Vital signs are typically monitored through a kit of connected devices (blood pressure cuff, pulse oximeter, thermometer) or through software-based, camera-based platforms. All data is transmitted through secure, HIPAA-compliant channels to the clinical care team.

Q: What happens if a patient's condition worsens at home? A: HaH programs have clear protocols for escalation. Based on remote vital signs data and telehealth check-ins, the care team can dispatch a nurse or paramedic for an urgent in-person visit or, if necessary, arrange for immediate transport back to the hospital.

Recovering from a major health event is a journey, and leading health systems are now extending their high-acuity care beyond the hospital walls. Circadify is at the forefront of addressing the technological challenges in this space, developing solutions that make remote monitoring more accessible and reliable for both patients and providers. To learn more about launching or scaling a remote care program, explore our RPM pilot program at circadify.com/solutions/remote-patient-monitoring.